A caged doxycycline analogue for photoactivated gene expression
A caged doxycycline analogue for photoactivated gene expression
复制标题
DOI:
10.1002/anie.200503339
复制
发表时间:
2006-01-01
影响因子:
16.6
通讯作者:
Cürten, B
中科院分区:
文献类型:
--
作者:
Cambridge, SB;Geissler, D;Cürten, B
Conditional gene-expression paradigms are crucial tools for the study of genes and gene functions. However, none of the currently available paradigms permits transgene expression with high spatial and temporal resolution; rather, they usually rely on specific expression patterns enabled by endogenous promoters. To improve the resolution of transgene expression, we synthesized a photosensitive (“caged”) doxycycline analogue for precise light-controlled activation of genes based on the “Tet-on”(Tet= tetracycline) system.[1] Because of the ease and precision with which light can be manipulated, this approach should make it possible to target subsets of cells for transgene expression which can range from single cells and tissue patches to whole organs.[2] To implement a photoactivated gene-expression system that is generally applicable in any organism at any stage, we based our approach on a conditional gene-expression paradigm that uses a small, membrane-permeant molecule for induction. The most prominent inducible system by far is the Tet system, which is commonly used for the induction of transgenes in cell culture, tissues, and whole organisms.[1] The most potent analogue for the Tet system is doxycycline, which can bind to a modified and mutated version of the Tet repressor fused to a transcriptional activation domain (rtTA) and induce transgenes under the control of the Tet promoter.[3] Because doxycycline (Scheme 1) has several functional groups that may be derivatized, it was necessary to specifically target a group that is essential for transcriptional activity and block this activity by “caging” with a photosensitive protecting group. It was previously shown that the phenolic β-diketone system (highlighted in red, Scheme 1) is important for the formation of the doxycycline–magnesium complex, which binds to the rtTA protein with high affinity.[4] We therefore attempted to generate a 1-(4, 5-dimethoxy-2-nitrophenyl) ethyl (DMNPE) ether of doxycycline (DMNPE-caged doxycycline) from the commercially available doxycycline hyclate (hydrochloride hemiethanolate hemihydrate) with the DMNPE moiety attached at the phenolic β-diketone system.